{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:18:59Z","timestamp":1784575139830,"version":"3.55.0"},"reference-count":23,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013945","name":"Institut de Recherches Internationales Servier","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013945","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2025,3,28]]},"DOI":"10.1080\/14796694.2025.2469467","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:17:16Z","timestamp":1740269836000},"page":"959-965","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["NALIRIFOX in Japanese treatment-na\u00efve patients with metastatic pancreatic adenocarcinoma: an open-label, phase II trial design"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4050-2086","authenticated-orcid":false,"given":"Masafumi","family":"Ikeda","sequence":"first","affiliation":[{"name":"National Cancer Center Hospital East","place":["Kashiwa, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-807X","authenticated-orcid":false,"given":"Takuji","family":"Okusaka","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4480-0029","authenticated-orcid":false,"given":"Makoto","family":"Ueno","sequence":"additional","affiliation":[{"name":"Kanagawa Cancer Center","place":["Yokohama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5666-1970","authenticated-orcid":false,"given":"Masato","family":"Ozaka","sequence":"additional","affiliation":[{"name":"Cancer Institute Hospital of Japanese Foundation for Cancer Research","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6527-5409","authenticated-orcid":false,"given":"Sohei","family":"Satoi","sequence":"additional","affiliation":[{"name":"Kansai Medical University","place":["Osaka, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0218-9584","authenticated-orcid":false,"given":"Donia","family":"Skanji","sequence":"additional","affiliation":[{"name":"Institut de Recherches Internationales Servier","place":["Gif sur Yvette, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4731-7753","authenticated-orcid":false,"given":"L.","family":"Mart\u00edn-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Institut de Recherches Internationales Servier","place":["Gif sur Yvette, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6171-6729","authenticated-orcid":false,"given":"Nadia","family":"Amellal","sequence":"additional","affiliation":[{"name":"Institut de Recherches Internationales Servier","place":["Gif sur Yvette, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0663-6117","authenticated-orcid":false,"given":"Junji","family":"Furuse","sequence":"additional","affiliation":[{"name":"Kanagawa Cancer Center","place":["Yokohama, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/1758835919875568"},{"key":"e_1_3_7_4_1","unstructured":"Lurie RH Cardin DB Gabriela Chiorean E et al. NCCN guidelines version 1.2024 pancreatic adenocarcinoma. [cited 2024 Apr 4]. Available from: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1455"},{"key":"e_1_3_7_5_1","unstructured":"The American cancer society pancreatic cancer early detection diagnosis and staging. [cited 2024 Apr 3]. Available from: https:\/\/www.cancer.org\/cancer\/types\/pancreatic-cancer\/detection-diagnosis-staging.html"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.21037\/jgo-20-118"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-4037-3"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1104-5245"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26034"},{"key":"e_1_3_7_11_1","unstructured":"The world bank population ages 65 and above (% of total population) - Japan. [cited 2024 Apr 3]. Available from: https:\/\/data.worldbank.org\/indicator\/SP.POP.65UP.TO.ZS?end=2022&locations=JP&start=2022&view=bar"},{"key":"e_1_3_7_12_1","unstructured":"eMC gemzar 200mg powder for solution for infusion gemzar 1000mg powder for solution for infusion. [cited 2024 Apr 3]. Available from: https:\/\/web.archive.org\/web\/20170710202604\/https:\/\/www.medicines.org.uk\/emc\/medicine\/596"},{"key":"e_1_3_7_13_1","unstructured":"CancerNetwork ODAC recommends full approval for gemzar for pancreatic cancer. [cited 2024 Apr 3]. Available from: https:\/\/www.cancernetwork.com\/view\/odac-recommends-full-approval-gemzar-pancreatic-cancer"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.6.2403"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.433"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011923"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304369"},{"key":"e_1_3_7_18_1","unstructured":"National cancer institute FDA approves irinotecan liposome to treat pancreatic cancer. [cited 2024 Apr 3]. Available from: https:\/\/www.cancer.gov\/news-events\/cancer-currents-blog\/2015\/irinotecan-liposome-pancreatic"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3558"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01366-1"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_3_7_22_1","unstructured":"Common terminology criteria for adverse events (CTCAE) version 5.0: U.S. Department of health and human services. National Institutes of Health; 2017 Nov 27. Available from: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.05.467"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12501"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-2972-3"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2025.2469467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:45:18Z","timestamp":1762958718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2025.2469467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,3,28]]}},"alternative-id":["10.1080\/14796694.2025.2469467"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2025.2469467","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-10-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}